US 5,962,503 A · Use of cholinesterase inhibitors in the treatment of xerostomia

Abstract

There is provided the use of a cholinesterase inhibitor in the manufacture of a medicament for topical administration for use in the treatment of xerostomia

Claims2

Dependent claims

A method of treating xerostomia which comprises topical administration of a therapeutically effective quantity of a cholinesterase inhibitor to the oral mucosa of a mammalian patient suffering from, or susceptible to, such a condition.

Dependencies are inferred from the claim text.

Facts

Application

08/750,825Filed 13 Dec 1996

Priority

SE 950426729 Nov 1995

Granted

5 Oct 1999

Term ends

Not estimatedThe source records don’t support an estimate.

Classification6 codes

A61K 31/407
Having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil: condensed with other…
A61P 1/00
Drugs for disorders of the alimentary tract or the digestive system
A61P 1/02
Drugs for disorders of the alimentary tract or the digestive system: stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
A61P 43/00
Drugs for specific purposes, not provided for in groups a61p1/00-a61p41/00

Abstract

There is provided the use of a cholinesterase inhibitor in the manufacture of a medicament for topical administration for use in the treatment of xerostomia

Use of cholinesterase inhibitors in the treatment of xerostomia

Life of this patent

Abstract

Claims2

Use of cholinesterase inhibitors in the treatment of xerostomia

Life of this patent

Abstract

Claims2